Brexafemme (ibrexafungerp) is an antifungal that's used to treat vaginal yeast infections in adults and children who've started having menstrual periods. This medication can also help lessen the risk of having a vaginal yeast infection again. In general, the dose is 2 tablets by mouth twice a day for 1 day. Side effects of Brexafemme (ibrexafungerp) include diarrhea, nausea, and stomach pain. This medication has a risk of harming an unborn baby.
Brexafemme (ibrexafungerp) is a triterpernoid antifungal. This type of antifungal kills the fungus that's causing the yeast infection by blocking it from making an essential protein it needs for survival.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
In studies, most people reported complete relief of their vaginal yeast infection symptoms, like redness, itching, irritation, and burning, 1 to 2 weeks after taking Brexafemme (ibrexafungerp). In addition, most people felt continued symptom relief even 3 to 4 weeks after they took the medication.
In general, a dose of Brexafemme (ibrexafungerp) stays in your system for about 4 to 5 days. This time frame is based on the half-life of Brexafemme (ibrexafungerp), which is an estimate of the time it takes for your body to remove the medication from its system.
Children who've started having menstrual periods can take Brexafemme (ibrexafungerp). We don't know whether the medication works well or whether it's safe for children who haven't started their periods. Talk to your child's pediatrician to see what options are available for vaginal symptoms if your child hasn't started their periods yet.
The manufacturer doesn't say whether it's safe to drink alcohol while you're taking Brexafemme (ibrexafungerp). In general, drinking too much alcohol can affect how well your immune system can help fight your vaginal yeast infection. Speak with your primary care provider about your drinking habits and whether Brexafemme (ibrexafungerp) is appropriate and safe for you.
If you're able to become pregnant, it's important to use birth control during treatment with Brexafemme (ibrexafungerp) because the medication has the potential to harm an unborn baby if you take it while pregnant. Use birth control for the entire 6-month treatment period if you're taking Brexafemme (ibrexafungerp) to lessen recurrent vaginal yeast infections. Continue to use birth control for four days after your last dose of Brexafemme (ibrexafungerp). Birth control helps prevent pregnancy and lowers the risk of harm to an unborn baby if it gets exposed to the medication in the womb.
You're encouraged to report your pregnancy to the manufacturer (Scynexis) at 1-888-982-7299 if you find out that you're pregnant during treatment with Brexafemme (ibrexafungerp) or within four days of your last dose of the medication. The manufacturer has an optional pregnancy safety study that monitors your health and your baby's health. This is important because animal studies suggest that Brexafemme (ibrexafungerp) might have a risk of harming an unborn baby if it's taken during pregnancy.
Brexafemme (ibrexafungerp) and fluconazole (Diflucan) are different types of antifungals that can be used to treat vaginal yeast infections. The CDC regards fluconazole (Diflucan) as a first-choice option for treating vaginal yeast infections. In addition, you need to take 2 tablets of Brexafemme twice a day for 1 day. But for fluconazole (Diflucan), you just need to take 1 tablet of the medication once. Although Brexafemme is also approved to help lessen recurrent yeast infections, fluconazole (Diflucan) isn't. Speak with your primary care provider to help you compare the two medications.
Brexafemme (ibrexafungerp) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Brexafemme (ibrexafungerp) has the potential to cause serious harm to an unborn baby. In animal studies, Brexafemme (ibrexafungerp) caused rare birth defects and malformations. It's not known whether this risk applies to humans. But to be safe, you shouldn't take Brexafemme (ibrexafungerp) if you're pregnant.
If you can become pregnant, you'll need to take a pregnancy test before each dose of Brexafemme (ibrexafungerp). The results must be negative to make sure you're not pregnant. You'll also need to use birth control while you're taking Brexafemme (ibrexafungerp). Be sure to use birth control during the 6-month treatment period for recurrent vaginal yeast infections. Continue to use birth control for four more days after your last dose of the medication.
If you accidentally take Brexafemme (ibrexafungerp) while pregnant or find out that you're pregnant within four days of taking the medication, it's encouraged that you report your pregnancy to the manufacturer (Scynexis) at 1-888-982-7299. There's an optional pregnancy safety study that you can enroll in that monitors your health and your baby's health.
| Dosage | Quantity | Price as low as | Price per unit |
|---|---|---|---|
| 4 tablets of 150mg | 1 carton | $531.32 | $531.32 |
Each tablet contains 150 mg of ibrexafungerp.
Contraindications are specific health conditions or situations in which a person should not take a medication due to safety concerns. If you have any of the following conditions or if any of the following apply to you, let your healthcare provider know because Brexafemme (ibrexafungerp) will not be safe for you to take.